Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic tyrosine kinase inhibitors

Heterocyclic tyrosine kinase inhibitors

US Patent 9273028 · Granted Mar 1, 2016

Estimated economic value: $486,730,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydroquinazoline derivatives as selective cytotoxic agents2025
Heterocyclic PAD4 inhibitors2025
Hydroxypyrrolidine-substituted arylsulfonamide compounds with selective activity2025
Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase2025
Phenoxy and benzyloxy substituted psychoplastogens and uses thereof2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Inhibiting agents for Bruton's tyrosine kinase2025
Inhibiting agents for bruton's tyrosine kinase2024
Biaryl inhibitors of Bruton's tyrosine kinase2023
IRAK4 inhibiting agents2022
Inhibiting agents for Bruton's tyrosine kinase2022
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders2021